Abstract
Interleukin 6 is an important peptide regulatory factor with diverse biological activities including stimulation of acute phase protein synthesis. In this report we describe the effect of signal transduction pathway modulators on interleukin 6 mediated acute phase protein synthesis in a human hepatoma cell line Hep G2. Genistein, a tyrosine kinase inhibitor inhibited the interleukin 6 stimulated synthesis of acute phase proteins suggesting that a tyrosine kinase event participates in the signal transduction pathway. There was no evidence to suggest that protein kinase C had a stimulatory role although this or a related kinase may be involved in down-regulating the interleukin 6 signal.
MeSH terms
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
-
Acute-Phase Proteins / biosynthesis
-
Alkaloids / pharmacology
-
Carcinoma, Hepatocellular / physiopathology
-
Genistein
-
Humans
-
Interleukin-1 / pharmacology
-
Interleukin-6 / pharmacology*
-
Interleukin-6 / physiology
-
Isoflavones / pharmacology
-
Isoquinolines / pharmacology
-
Piperazines / pharmacology
-
Protein Kinase C / antagonists & inhibitors
-
Protein Kinase C / metabolism
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / metabolism
-
Signal Transduction / drug effects*
-
Signal Transduction / physiology
-
Staurosporine
-
Tetradecanoylphorbol Acetate / pharmacology
-
Tumor Cells, Cultured / drug effects*
-
Tumor Cells, Cultured / physiology
Substances
-
Acute-Phase Proteins
-
Alkaloids
-
Interleukin-1
-
Interleukin-6
-
Isoflavones
-
Isoquinolines
-
Piperazines
-
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
-
N-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide
-
Genistein
-
Protein-Tyrosine Kinases
-
Protein Kinase C
-
Staurosporine
-
Tetradecanoylphorbol Acetate